SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
4.760
+0.020 (0.42%)
At close: Jun 27, 2025, 4:00 PM
4.830
+0.070 (1.47%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Company Description

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption.

The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

SenesTech, Inc.
SenesTech logo
Country United States
Founded 2004
IPO Date Dec 8, 2016
Industry Specialty Chemicals
Sector Materials
Employees 23
CEO Joel Fruendt

Contact Details

Address:
777 West Pinnacle Peak Road, Suite B104
Phoenix, Arizona 85027
United States
Phone 928 779 4143
Website senestech.com

Stock Details

Ticker Symbol SNES
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001680378
CUSIP Number 81720R208
ISIN Number US81720R5054
Employer ID 20-2079805
SIC Code 2870

Key Executives

Name Position
Joel L. Fruendt Chief Executive Officer, President and Director
Thomas C. Chesterman M.B.A. Executive Vice President, Chief Financial Officer, Treasurer and Secretary
Robert Blum Investor Relations

Latest SEC Filings

Date Type Title
Jun 25, 2025 424B5 Filing
Jun 25, 2025 424B3 Prospectus
Jun 24, 2025 EFFECT Notice of Effectiveness
Jun 24, 2025 EFFECT Notice of Effectiveness
Jun 23, 2025 S-3/A [Amend] Registration statement under Securities Act of 1933
Jun 17, 2025 S-3 Registration statement under Securities Act of 1933
Jun 10, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G/A Filing
May 12, 2025 SCHEDULE 13G/A Filing
May 8, 2025 10-Q Quarterly Report